Jove
Visualize
Contáctanos

Videos de Conceptos Relacionados

Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors01:30

Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors

875
Angiotensin-converting enzyme (ACE), a vital component of the renin-angiotensin-aldosterone system, is abundant in lung endothelial cells. ACE converts the inactive decapeptide, angiotensin I, into the active octapeptide, angiotensin II. This potent vasoconstrictor narrows blood vessels, increasing resistance to blood flow and elevating blood pressure. Angiotensin II also stimulates aldosterone production, encouraging kidney cells to reabsorb more sodium and water from urine, thereby increasing...
875
Antihypertensive Drugs: Direct Renin Inhibitors01:25

Antihypertensive Drugs: Direct Renin Inhibitors

819
The renin-angiotensin-aldosterone system (RAAS) is an intricate physiological pathway involving numerous enzymes and hormones, including renin, angiotensin-converting enzyme (ACE), angiotensin I and II, and aldosterone. Imbalances within this system increase the production of angiotensin II and aldosterone. Increased angiotensin II levels promote vasoconstriction and blood pressure elevation. Concurrently, higher aldosterone levels stimulate sodium and water reabsorption in the kidneys,...
819
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

505
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
505
Antihypertensive Drugs: Angiotensin II Receptor Blockers01:30

Antihypertensive Drugs: Angiotensin II Receptor Blockers

915
In the renin-angiotensin-aldosterone system, a hormone called angiotensin II plays a crucial role. It binds to the AT1 receptors in vascular smooth muscles coupled with Gq proteins. The activation of these receptors activates an enzyme called phospholipase C, which releases two molecules: inositol trisphosphate and diacylglycerol. These molecules cause a chain reaction that leads to the phosphorylation of myosin light chains and promotes interaction between actin and myosin, leading to smooth...
915
Hypertension II: Pathophysiology01:29

Hypertension II: Pathophysiology

77
Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
77
Antihypertensive Drugs: Potassium-Sparing Diuretics01:28

Antihypertensive Drugs: Potassium-Sparing Diuretics

761
Liddle syndrome is a genetically inherited form of hypertension characterized by the overactivity of epithelial sodium channels in the nephron, the functional unit of the kidney. This heightened activity leads to increased sodium reabsorption and excessive excretion of potassium. To counteract this, potassium-sparing diuretics such as amiloride are used. They function by blocking these sodium channels, thereby reducing the influx of sodium into the epithelial cells and minimizing the loss of...
761

También podría leer

Artículos Relacionados

Artículos vinculados a este trabajo por autores compartidos, revista y gráfico de citas.

Ordenar por
Same authorSame journal

Administration of Aspirin and Aqueous Leaf Extract of Terminalia Catappa Reduces Leukocytosis with Risk of Developing Thrombocytosis in Diabetic Wistar Rats.

Cardiovascular & hematological agents in medicinal chemistry·2026
Same author

Quantity of fat consumed predisposes cardiac tissues to greater metabolic risk than their level of saturation.

Scientific reports·2025
Same author

Aqueous extract of Peristrophe bivalvis leaf alleviates oxidative stress in L-NAME-induced hypertensive rats.

BMC complementary medicine and therapies·2025
Same author

Vitamin D in male sexual functions: unwrapping the sunshine hormone activities in erectile function and beyond.

Frontiers in reproductive health·2025
Same author

Transformative Role of Artificial Intelligence in Drug Discovery and Translational Medicine: Innovations, Challenges, and Future Prospects.

Drug design, development and therapy·2025
Same author

Effects of Watching <i>vs</i>. Performing Walking and Stair-climbing Exercises on Physiological Parameters in Healthy Males.

Cardiovascular & hematological disorders drug targets·2025
JoVE
x logofacebook logolinkedin logoyoutube logo
ACERCA DE JoVE
Visión GeneralLiderazgoBlogCentro de Ayuda JoVE
AUTORES
Proceso de PublicaciónConsejo EditorialAlcance y PolíticasRevisión por ParesPreguntas FrecuentesEnviar
BIBLIOTECARIOS
TestimoniosSuscripcionesAccesoRecursosConsejo Asesor de BibliotecasPreguntas Frecuentes
INVESTIGACIÓN
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchivo
EDUCACIÓN
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualCentro de Recursos para ProfesoresSitio de Profesores
Términos y Condiciones de Uso
Política de Privacidad
Políticas

Video Experimental Relacionado

Updated: Sep 10, 2025

Author Spotlight: Exploring Huotan Jiedu Tongluo Decoction as an Antihypertensive Drug
05:57

Author Spotlight: Exploring Huotan Jiedu Tongluo Decoction as an Antihypertensive Drug

Published on: May 17, 2024

848

El potencial antioxidante y antilipidémico del inhibidor de la enzima de conversión de la angiotensina (Ramipril) en

Esther Oluwasola Aluko1, Ezekiel Etim Ben1, Grace Edet Bassey1

  • 1Physiology Department, Faculty of Basic Medical Sciences, University of Uyo, Uyo, Akwa-Ibom State, Nigeria.

Cardiovascular & hematological agents in medicinal chemistry
|August 24, 2025
PubMed
Resumen

Ramipril, un inhibidor de la enzima convertidora de angiotensina, reduce eficazmente la presión arterial y al mismo tiempo reduce el estrés oxidativo y mejora los perfiles lipídicos en ratas hipertensas. Esto sugiere su potencial para tratar el síndrome metabólico junto con la hipertensión.

Palabras clave:
Estero metílico de la N-nitro-L-argininaRamipril y sus derivadosLas enzimas antioxidantesíndices aterogénicos.contenido de lípidosÁcido acetilsalicílico

Más Videos Relacionados

Improved Renal Denervation Mitigated Hypertension Induced by Angiotensin II Infusion
08:35

Improved Renal Denervation Mitigated Hypertension Induced by Angiotensin II Infusion

Published on: May 26, 2022

3.4K
A Modified Two Kidney One Clip Mouse Model of Renin Regulation in Renal Artery Stenosis
08:21

A Modified Two Kidney One Clip Mouse Model of Renin Regulation in Renal Artery Stenosis

Published on: October 26, 2020

5.0K

Videos de Experimentos Relacionados

Last Updated: Sep 10, 2025

Author Spotlight: Exploring Huotan Jiedu Tongluo Decoction as an Antihypertensive Drug
05:57

Author Spotlight: Exploring Huotan Jiedu Tongluo Decoction as an Antihypertensive Drug

Published on: May 17, 2024

848
Improved Renal Denervation Mitigated Hypertension Induced by Angiotensin II Infusion
08:35

Improved Renal Denervation Mitigated Hypertension Induced by Angiotensin II Infusion

Published on: May 26, 2022

3.4K
A Modified Two Kidney One Clip Mouse Model of Renin Regulation in Renal Artery Stenosis
08:21

A Modified Two Kidney One Clip Mouse Model of Renin Regulation in Renal Artery Stenosis

Published on: October 26, 2020

5.0K

Área de la Ciencia:

  • Farmacología
  • Investigación cardiovascular
  • Trastornos del metabolismo

Sus antecedentes:

  • La hipertensión está relacionada con el estrés oxidativo y trastornos metabólicos como la hiperlipidemia.
  • Los inhibidores de la enzima de conversión de la angiotensina (ECA) pueden ofrecer beneficios más allá de la reducción de la presión arterial.

Objetivo del estudio:

  • Investigar los efectos de los inhibidores de la ECA sobre el estrés oxidativo y la dislipidemia en la hipertensión inducida por L-NAME en ratas.

Principales métodos:

  • Las ratas Wistar fueron inducidas con hipertensión usando L-NAME.
  • Los grupos tratados recibieron agua destilada o ramipril durante cinco semanas.
  • Se analizaron la presión arterial, los marcadores de estrés oxidativo sérico y los perfiles lipídicos.

Principales resultados:

  • Ramipril redujo significativamente la presión arterial en comparación con el grupo hipertendido.
  • Los marcadores de estrés oxidativo (malondialdehído) disminuyeron y las enzimas antioxidantes aumentaron con el tratamiento con ramipril.
  • Ramipril mejoró los perfiles lipídicos, reduciendo el colesterol total y los triglicéridos mientras aumentaba el colesterol HDL.

Conclusiones:

  • Ramipril muestra efectos antihipertensivos, antioxidantes y antidislipemicos significativos.
  • Los inhibidores de la ECA como el ramipril muestran potencial como tratamiento para el síndrome metabólico en condiciones hipertensivas.